Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Single Dose of Anti-HBsAg Antibody-Encoding mRNA-LNPs Suppressed HBsAg Expression: a Potential Cure of Chronic Hepatitis B Virus Infection

7 Jul 2022

Abstract excerpt

It is the first time that mRNA-LNPs have been used to express anti-HBsAg antibodies (G12-scFv, G12-scFv-Fc, and G12-IgG). G12-scFv-Fc- and G12-IgG-encoding mRNA-LNPs exerted a sustained effect on HBsAg serum clearance in the adeno-associated virus (AAV)/HBV mouse model with persistent HBsAg expression. These findings may provide a new design of combination therapy for functional cure of HBV. For example, this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Immunotherapy and Immune Responses
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35862767
DOI: 10.1128/mbio.01612-22

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Single Dose of Anti-HBsAg Antibody-Encoding mRNA-LNPs Suppressed HBsAg Expression: a Potential Cure of Chronic Hepatitis B Virus InfectionPMID 35862767Read ↗

A multivalent mRNA-LNP therapeutic vaccine with broad cross-genotype immunogenicity elicits clearance of HBV infected hepatocytesSemantic proximity Read ↗

The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice.Semantic proximity Read ↗

Molecular therapeutics of HBV.Semantic proximity Read ↗

Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.Semantic proximity Read ↗

An aptamer targets HBV core protein and suppresses HBV replication in HepG2.2.15 cellsSemantic proximity Read ↗

Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA deliverySemantic proximity Read ↗

Production, characterization and in vitro testing of HBcAg-specific VHH intrabodiesSemantic proximity Read ↗

Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen Titers.Semantic proximity Read ↗

Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.Semantic proximity Read ↗

Low immunogenic bio-nanocapsule based on hepatitis B virus escape mutants.Semantic proximity Read ↗

CRISPR-Cas13b-mediated suppression of HBV replication and protein expressionSemantic proximity Read ↗

Humanized mouse model reveals the immunogenicity of Hepatitis B Virus vaccine candidates produced in CRISPR/Cas9-edited Nicotiana benthamianaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.